Sign up to save your podcasts
Or
Share BTK Inhibitors in Multiple Sclerosis Treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BTK Inhibitors in Multiple Sclerosis Treatment
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
284284 ratings
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
NEJM This Week
324 Listeners
JAMA Clinical Reviews
498 Listeners
Practical Neurology Podcast
47 Listeners
Mayo Clinic Talks
295 Listeners
The Curbsiders Internal Medicine Podcast
3,358 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
190 Listeners
The Clinical Problem Solvers
515 Listeners
Neurology Minute
138 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Neurology Exam Prep Podcast
191 Listeners
The Curious Clinicians
373 Listeners
Continuum Audio
83 Listeners